Immunovia AB (publ) (LON:0G8X)
0.2000
-0.0090 (-4.31%)
At close: Feb 3, 2026
Immunovia AB Revenue
Immunovia AB had revenue of 101.00K SEK in the quarter ending September 30, 2025, a decrease of -57.02%. This brings the company's revenue in the last twelve months to 786.00K, up 24.37% year-over-year. In the year 2024, Immunovia AB had annual revenue of 931.00K, down -40.89%.
Revenue (ttm)
786.00K SEK
Revenue Growth
+24.37%
P/S Ratio
160.33
Revenue / Employee
65.50K SEK
Employees
12
Market Cap
9.95M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 931.00K | -644.00K | -40.89% |
| Dec 31, 2023 | 1.58M | 430.00K | 37.55% |
| Dec 31, 2022 | 1.15M | 301.00K | 35.66% |
| Dec 31, 2021 | 844.00K | 482.00K | 133.15% |
| Dec 31, 2020 | 362.00K | 6.00K | 1.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| IXICO | 6.53M |
| RUA Life Sciences | 4.11M |
| CelLBxHealth | 2.62M |
| Verici Dx | 1.40M |
Immunovia AB News
- 2 months ago - Immunovia AB (publ) 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Immunovia AB (FRA:1YR) Q3 2025 Earnings Call Highlights: Transition to Commercial Stage with ... - GuruFocus
- 2 months ago - Q3 2025 Immunovia AB (publ) Earnings Call Transcript - GuruFocus
- 2 months ago - Immunovia AB (publ) (IMMVF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Q2 2025 Immunovia AB (publ) Earnings Call Transcript - GuruFocus
- 1 year ago - Immunovia AB (LTS:0G8X) Q4 2024 Earnings Call Highlights: Breakthroughs in Testing and ... - GuruFocus
- 1 year ago - Q4 2024 Immunovia AB (publ) Earnings Call Transcript - GuruFocus
- 1 year ago - Immunovia reports Q4 results - Seeking Alpha